Related Experiment Video
Updated: May 5, 2026

A Hydrogel Construct and Fibrin-based Glue Approach to Deliver Therapeutics in a Murine Myocardial Infarction Model.
Published on: June 14, 2015
Synthetic-Polymer-Based Cardiac Patches for MI-Induced Heart Failure Treatment: A Review
Ahmed Eliwa1,2, Mohamed K Abbas3, Maryam Al-Ejji3
1College of Medicine, Qatar University, Doha P.O. Box 2713, Qatar.
Insights
Synthetic polymer cardiac patches offer a promising treatment for heart failure following myocardial infarction (MI). These advanced scaffolds improve cardiac function and provide mechanical support, addressing critical needs in cardiovascular disease therapy.
Area of Science:
- Biomedical Engineering
- Materials Science
- Cardiovascular Research
Background:
- Myocardial infarction (MI) leads to heart failure due to cardiac tissue damage.
- Cardiac patches are polymer scaffolds designed to repair heart tissue and improve function.
- Current research focuses on synthetic polymers for advanced cardiac patch fabrication.
Purpose of the Study:
- To review recent advancements in synthetic-polymer-based cardiac patches for treating MI-induced heart failure.
- To analyze the mechanical and chemical properties of various synthetic polymers used in cardiac patches.
- To outline challenges and future directions in cardiac patch technology.
Main Methods:
- Literature review of synthetic polymer cardiac patches for myocardial infarction.
- Analysis of mechanical and chemical characteristics of different synthetic polymers.
- Discussion of benefits, drawbacks, challenges, and future prospects.
Main Results:
- Synthetic polymer cardiac patches demonstrate significant therapeutic effects in preclinical models.
- Specific polymers offer distinct advantages in terms of mechanical support and bioactive substance delivery.
- Key challenges include long-term stability, integration with host tissue, and scalable manufacturing.
Conclusions:
- Synthetic polymer cardiac patches represent a viable strategy for mitigating heart failure post-MI.
- Tailoring polymer properties is crucial for optimizing patch performance and patient outcomes.
- Continued innovation is needed to overcome current limitations and advance clinical translation.
Abstract:
Myocardial infarction (MI) is one of the prevalent cardiovascular diseases, which is caused by obstruction of one or more coronary arteries, leading to cardiac tissue ischemia and death. One of the main consequences of MI is heart failure, which is defined as dysfunction of the heart muscle to pump blood into peripheral organs. Cardiac patches have drawn a lot of interest as a potentially effective way to restore damaged cardiac tissue and enhance its functionality. They are polymer-based scaffolds designed to be implanted on the heart surface, and they have shown a significant therapeutic effect in the treatment of MI by improving cardiac function and providing mechanical support for the infarction site by the delivery of various bioactive substances or cells. Several biomaterials with specific mechanical and chemical characteristics have been widely used as a scaffold in the process of fabricating cardiac patches. In this study, we focus on the latest developments in the manufacturing of synthetic-polymer-based cardiac patches used to treat heart failure induced by myocardial infarction. We describe the mechanical and chemical characteristics of several synthetic polymers and highlight the main benefits and drawbacks of each type. An overview of the major challenges and the future development directions in the field of cardiac patches is also highlighted.
Related Concept Videos
Myocarditis III: Medical Management
Heart Failure Drugs: Inotropic Agents
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy

